Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipoprotein(a) and its Significance in Cardiovascular Disease
Freddy Duarte Lau, Robert P. Giugliano
JAMA Cardiology (2022) Vol. 7, Iss. 7, pp. 760-760
Closed Access | Times Cited: 199

Showing 1-25 of 199 citing articles:

Atherosclerosis and Inflammation: Insights from the Theory of General Pathological Processes
Evgeni Gusev, Alexey Sarapultsev
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7910-7910
Open Access | Times Cited: 119
Atherosclerotic plaque stabilization and regression: a review of clinical evidence
Ashish Sarraju, Steven E. Nissen
Nature Reviews Cardiology (2024) Vol. 21, Iss. 7, pp. 487-497
Closed Access | Times Cited: 32
Lipoprotein(a), C-Reactive Protein, and Cardiovascular Risk in Primary and Secondary Prevention Populations
Aeron Small, Ashley Pournamdari, Giorgio Melloni, et al.
JAMA Cardiology (2024) Vol. 9, Iss. 4, pp. 385-385
Closed Access | Times Cited: 32
Hyperlipidemia and Cardiovascular Risk in Children and Adolescents
Francesca Mainieri, Saverio La Bella, Francesco Chiarelli
Biomedicines (2023) Vol. 11, Iss. 3, pp. 809-809
Open Access | Times Cited: 29
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Jingfei Chen, Zhenfei Fang, Qin Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Vascular Calcification: A Passive Process That Requires Active Inhibition
Ricardo Villa‐Bellosta
Biology (2024) Vol. 13, Iss. 2, pp. 111-111
Open Access | Times Cited: 14
The future of valvular heart disease assessment and therapy
Partho P. Sengupta, Jolanda Kluin, Seung‐Pyo Lee, et al.
The Lancet (2024) Vol. 403, Iss. 10436, pp. 1590-1602
Open Access | Times Cited: 9
Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes (RELACS Study): impact of Lipoprotein(a) levels on the premature coronary event and the severity of coronary artery disease.
Arturo Cesaro, Vincenzo Acerbo, Francesco Scialla, et al.
Nutrition Metabolism and Cardiovascular Diseases (2024), pp. 103843-103843
Closed Access | Times Cited: 9
Delving into biomarkers and predictive modeling for CVD mortality: a 20-year cohort study
Zhen Wu, Abdullahi Mohamud Hilowle, Zhou Ying, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Lipoprotein(a), remote ischemic conditioning, and stroke recurrence in patients with symptomatic intracranial atherosclerotic stenosis
Chuanjie Wu, Chengbei Hou, Wenbo Zhao, et al.
Neurotherapeutics (2025), pp. e00579-e00579
Open Access | Times Cited: 1
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
Sailimai Man, Yuangang Zu, Xiaochen Yang, et al.
Journal of the American College of Cardiology (2025)
Closed Access | Times Cited: 1
Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a)
Constantine E. Kosmas, Maria D. Bousvarou, E Papakonstantinou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13622-13622
Open Access | Times Cited: 17
The association of lipoprotein(a) and coronary artery calcium in asymptomatic patients: a systematic review and meta-analysis
F Martignoni, José Eduardo RL Júnior, Isabela Reis Marques, et al.
European Journal of Preventive Cardiology (2024) Vol. 31, Iss. 6, pp. 732-741
Closed Access | Times Cited: 8
Effects of Lipoproteins on Metabolic Health
Obaida Albitar, Crystal D’Souza, Ernest Adeghate
Nutrients (2024) Vol. 16, Iss. 13, pp. 2156-2156
Open Access | Times Cited: 8
Synergetic impact of lipoprotein(a) and fibrinogen on stroke in coronary artery disease patients
Cheng Xi Yang, Cheng‐Gang Zhu, Yong‐Gang Sui, et al.
European Journal of Clinical Investigation (2024) Vol. 54, Iss. 6
Closed Access | Times Cited: 7
Extracellular DNA as potential contributors to pathological calcification
Long-zhang Niu, Yi‐na Zhu, Mei‐chen Wan, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 7
Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of Atherosclerosis
Ting Qin, Tianyi Ma, Kang Huang, et al.
Current Atherosclerosis Reports (2024) Vol. 26, Iss. 8, pp. 383-394
Open Access | Times Cited: 7
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention
Umidakhon Makhmudova, Elisabeth Steinhagen‐Thiessen, Massimo Volpe, et al.
Cardiovascular Research (2024) Vol. 120, Iss. 10, pp. 1107-1125
Open Access | Times Cited: 7
Clot or Not? Reviewing the Reciprocal Regulation Between Lipids and Blood Clotting
Ziyu Zhang, Maya Rodriguez, Ze Zheng
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 3, pp. 533-544
Open Access | Times Cited: 6
Crucial Interactions between Altered Plasma Trace Elements and Fatty Acids Unbalance Ratio to Management of Systemic Arterial Hypertension in Diabetic Patients: Focus on Endothelial Dysfunction
Inès Gouaref, Amel Otmane, Mohamed Makrelouf, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9288-9288
Open Access | Times Cited: 6
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations
Natalie C. Ward, Gerald F. Watts, Warrick Bishop, et al.
Heart Lung and Circulation (2023) Vol. 32, Iss. 3, pp. 287-296
Closed Access | Times Cited: 16
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies
Ibrahim S. Alhomoud, Azita H. Talasaz, Anurag Mehta, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2023) Vol. 43, Iss. 10, pp. 1051-1063
Open Access | Times Cited: 16
Atherosclerosis Calcification: Focus on Lipoproteins
Jaap G. Neels, Georges Lefthériotis, Giulia Chinetti
Metabolites (2023) Vol. 13, Iss. 3, pp. 457-457
Open Access | Times Cited: 15
LP(a): Structure, Genetics, Associated Cardiovascular Risk, and Emerging Therapeutics
Erfan Tasdighi, Rishav Adhikari, Omar Almaadawy, et al.
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 135-157
Closed Access | Times Cited: 15
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
Alberico L. Catapano, Lâle Tokgözoğlu, Maciej Banach, et al.
Atherosclerosis (2023) Vol. 370, pp. 5-11
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top